Market Overview:
The global flow cytometry market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for cell-based and bead-based flow cytometry techniques across different applications such as academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. In addition, the growing focus on personalized medicine is also contributing to the growth of this market. North America dominates the global flow cytometry market followed by Europe and Asia Pacific.
Product Definition:
Flow cytometry is a technique used to count, characterize and sort particles in a fluid suspension. It can be used to study single cells or cell populations in vitro or in vivo.
Cell-based flow cytometry:
Cell-based flow cytometry is a technique used for cell counting and analyzing based on their size, shape, and granularity. It is one of the most important techniques used in Flow Cytometry (FC) market. Cell-based flow cytometry helps to analyze cellular properties such as viability, proliferation & growth rate, genetic expression level & characteristics of cells under study.
Bead-based flow cytometry:
Bead-based flow cytometry is a technique that involves the use of beads as carriers for cell analysis. The technique provides high sensitivity and accuracy in the detection of cellular parameters such as size, shape, and surface markers. It also facilitates quantification of different types of cells present in biological fluids such as blood or serum.
Application Insights:
The academic & research institutes segment held the largest market share in 2017. This is attributed to the rising number of flow cytometry-based studies for cancer diagnostics and drug development. Furthermore, increasing R&D activities by major players such as ¢â‚¬Å“AbbVie, Inc., Amgen Inc., and Merck KGaA¢â‚¬ for developing new flow cytometry-based tests is expected to propel revenue growth during the forecast period.
Hospitals & clinical testing laboratories are anticipated to register a significant CAGR over the forecast period owing to an increase in demand for point-of-care diagnostic tests that can be performed quickly with minimal resources required by clinicians or technicians involved in its performance. Moreover, an increase in government initiatives aimed at improving access to high quality healthcare services across various regions is further expected fuel industry expansion during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of flow cytometry service providers and manufacturers, increasing R&D activities for cancer & other diseases, and high adoption rate for technologically advanced flow cytometry solutions in this region. Moreover, growing investments by governments for developing novel therapies through research is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness about early diagnosis among people leading to an increase in demand for diagnostic services which eventually drives FMC business.
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of cancer and other diseases
- Technological advancements in flow cytometry instruments and consumables
- Growing number of research studies utilizing flow cytometry techniques
- Increasing use of flow cytometry in clinical diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Flow Cytometry Market Research Report
By Type
Cell-based flow cytometry, Bead-based flow cytometry
By Application
Academic & research institutes, Hospitals & clinical testing laboratories, Pharmaceutical & biotechnology companies Â
By Companies
Beckman Coulter, Sysmex, Agilent Technologies, Merck, Apogee, Bio-Rad Laboratories, Thermo Fisher, Stratedigm, Luminex, Miltenyi Biotec, GE
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Flow Cytometry Market Report Segments:
The global Flow Cytometry market is segmented on the basis of:
Types
Cell-based flow cytometry, Bead-based flow cytometry
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & research institutes, Hospitals & clinical testing laboratories, Pharmaceutical & biotechnology companies Â
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- Sysmex
- Agilent Technologies
- Merck
- Apogee
- Bio-Rad Laboratories
- Thermo Fisher
- Stratedigm
- Luminex
- Miltenyi Biotec
- GE
Highlights of The Flow Cytometry Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell-based flow cytometry
- Bead-based flow cytometry
- By Application:
- Academic & research institutes
- Hospitals & clinical testing laboratories
- Pharmaceutical & biotechnology companies Â
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flow Cytometry Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flow cytometry is a technique used to measure the number and size of cells in a sample.
Some of the key players operating in the flow cytometry market are Beckman Coulter, Sysmex, Agilent Technologies, Merck, Apogee, Bio-Rad Laboratories, Thermo Fisher, Stratedigm, Luminex, Miltenyi Biotec, GE.
The flow cytometry market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Flow Cytometry Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Flow Cytometry Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Flow Cytometry Market - Supply Chain
4.5. Global Flow Cytometry Market Forecast
4.5.1. Flow Cytometry Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Flow Cytometry Market Size (000 Units) and Y-o-Y Growth
4.5.3. Flow Cytometry Market Absolute $ Opportunity
5. Global Flow Cytometry Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Flow Cytometry Market Size and Volume Forecast by Type
5.3.1. Cell-based flow cytometry
5.3.2. Bead-based flow cytometry
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Flow Cytometry Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Flow Cytometry Market Size and Volume Forecast by Application
6.3.1. Academic & research institutes
6.3.2. Hospitals & clinical testing laboratories
6.3.3. Pharmaceutical & biotechnology companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Flow Cytometry Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Flow Cytometry Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Flow Cytometry Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Flow Cytometry Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Flow Cytometry Demand Share Forecast, 2019-2029
9. North America Flow Cytometry Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Flow Cytometry Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Flow Cytometry Market Size and Volume Forecast by Application
9.4.1. Academic & research institutes
9.4.2. Hospitals & clinical testing laboratories
9.4.3. Pharmaceutical & biotechnology companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Flow Cytometry Market Size and Volume Forecast by Type
9.7.1. Cell-based flow cytometry
9.7.2. Bead-based flow cytometry
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Flow Cytometry Demand Share Forecast, 2019-2029
10. Latin America Flow Cytometry Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Flow Cytometry Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Flow Cytometry Market Size and Volume Forecast by Application
10.4.1. Academic & research institutes
10.4.2. Hospitals & clinical testing laboratories
10.4.3. Pharmaceutical & biotechnology companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Flow Cytometry Market Size and Volume Forecast by Type
10.7.1. Cell-based flow cytometry
10.7.2. Bead-based flow cytometry
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Flow Cytometry Demand Share Forecast, 2019-2029
11. Europe Flow Cytometry Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Flow Cytometry Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Flow Cytometry Market Size and Volume Forecast by Application
11.4.1. Academic & research institutes
11.4.2. Hospitals & clinical testing laboratories
11.4.3. Pharmaceutical & biotechnology companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Flow Cytometry Market Size and Volume Forecast by Type
11.7.1. Cell-based flow cytometry
11.7.2. Bead-based flow cytometry
11.8. Basis Point Share (BPS) Analysis by ype
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Flow Cytometry Demand Share, 2019-2029
12. Asia Pacific Flow Cytometry Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Flow Cytometry Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Flow Cytometry Market Size and Volume Forecast by Application
12.4.1. Academic & research institutes
12.4.2. Hospitals & clinical testing laboratories
12.4.3. Pharmaceutical & biotechnology companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Flow Cytometry Market Size and Volume Forecast by Type
12.7.1. Cell-based flow cytometry
12.7.2. Bead-based flow cytometry
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Flow Cytometry Demand Share, 2019-2029
13. Middle East & Africa Flow Cytometry Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Flow Cytometry Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Flow Cytometry Market Size and Volume Forecast by Application
13.4.1. Academic & research institutes
13.4.2. Hospitals & clinical testing laboratories
13.4.3. Pharmaceutical & biotechnology companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Flow Cytometry Market Size and Volume Forecast by Type
13.7.1. Cell-based flow cytometry
13.7.2. Bead-based flow cytometry
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Flow Cytometry Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Flow Cytometry Market: Market Share Analysis
14.2. Flow Cytometry Distributors and Customers
14.3. Flow Cytometry Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Beckman Coulter
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sysmex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Agilent Technologies
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Apogee
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Thermo Fisher
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Stratedigm
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Luminex
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Miltenyi Biotec
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. GE
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
